BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This clinical investigation is being performed to compare the effect of BOL-303259-X dosed
once daily (QD) with timolol maleate 0.5% dosed twice daily (BID) in reducing intraocular
pressure (IOP) measured over a 24-hour period in subjects with open-angle glaucoma (OAG) or
ocular hypertension (OHT).